| Company/Division name | Arranta Bio |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 500 |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2022 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 150 |
| City reshored to: | Boxborough |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biotherapeutic products, microbiome products |
| What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Skilled workforce availability/training |
